XML 142 R129.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment Information - Information by Segment (Details)
$ in Millions
12 Months Ended
Feb. 26, 2020
USD ($)
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Business segment information        
Number of reportable segments | segment   3    
Total revenue   $ 1,987.5 $ 2,072.6 $ 1,895.6
Operating Income   248.3 300.9 262.4
Assets   3,049.0 2,771.5  
Capital Expenditures $ 12.3 97.2 73.0 49.2
Depreciation and Amortization   80.4 75.6 64.9
Operating segments        
Business segment information        
Assets   2,964.5 2,711.6  
Eliminations        
Business segment information        
Total revenue   (12.0) (14.9) (6.2)
Corporate, eliminations and other        
Business segment information        
Operating Income   (55.3) (46.2) (44.5)
Assets   (4.2) (4.7)  
BSI Life Science        
Business segment information        
Capital Expenditures   59.1 44.4 27.6
Depreciation and Amortization   35.0 30.5 24.0
BSI Life Science | Operating segments        
Business segment information        
Total revenue   1,253.9 1,244.9 1,138.9
Operating Income   273.8 290.3 244.0
BSI NANO        
Business segment information        
Capital Expenditures   10.6 18.5 11.6
Depreciation and Amortization   35.7 35.9 32.2
BSI NANO | Operating segments        
Business segment information        
Total revenue   556.1 632.7 568.1
Operating Income   23.6 40.4 48.4
BEST        
Business segment information        
Capital Expenditures   10.1 5.4 6.4
Depreciation and Amortization   5.7 5.4 4.7
BEST | Operating segments        
Business segment information        
Total revenue   189.5 209.9 194.8
Operating Income   6.2 16.4 14.5
Assets   88.7 64.6  
Corporate        
Business segment information        
Capital Expenditures   17.4 4.7 3.6
Depreciation and Amortization   $ 4.0 $ 3.8 $ 4.0